Form 4 for AXGN Axogen, Inc.
Accepted 2025-09-16 00:00:00 ET · period of report 2025-09-13 · accession 0000805928-25-000116 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-16 | 2025-09-16 | AXGN | DeVinney Erick Wayne | Chief Innovation Off | S - Sale | $16.29 | -1,137 | 220.6K | -0.5% | -$18.5K | |
| 2025-09-16 | 2025-09-13 | AXGN | DeVinney Erick Wayne | Chief Innovation Off | A - Grant | $0.00 | +2,500 | 221.8K | +1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-16 | S | D | 1,137 | $16.29 | 220,649 | D | — | — | (F2) Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance stock units ("PSUs") on September 13, 2025. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. |
| 2 | Common | Common Stock | 2025-09-13 | A | A | 2,500 | $0.00 | 221,786 | D | — | — | (F1) This reflects the number of shares issued upon the attainment of certain performance criteria. |